
For decades, the United States led the charge in the pursuit of brain-computer interface technology, betting big on bold, high-risk breakthroughs that promised to revolutionise medicine and human-machine integration.
In the end, it is China crossing the finish line first.
Advertisement
After decades of this technology being stuck in clinical trials globally, this feat makes their Neural Electronic Opportunity (Neo) implant the first invasive device in the world to be available outside trials.
Advertisement
The development of BCI has been defined by a difficult trade-off: a non-invasive approach that sacrifices precision or an invasive approach that sacrifices safety.

Don't Miss:
-
Egypt sentences TV presenter, 11 others to death in drugs case
-
2 pilots killed after Greek air force plane crashes at annual air show
-
US ambassador calls violent Israeli settlers ‘terrorists’ after weeks of West Bank unrest
-
US ‘disables’ or ‘destroys’ 3 Iran oil tankers after warships targeted
-
Hong Kong’s first astronaut Lai Ka-ying to give live lecture from space

RECAP: Asia Sentinel Stories for August 2026
Taiwan’s Habit of Releasing Soldiers’ Full Names Seems Risky
White House pick to run Venezuela oil deal under investigation in two countries